Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathanael R Fillmore

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
MMWR. Morbidity and Mortality Weekly Report|January 25, 2024
Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 - Veterans Health Administration, March-September 2022Paul A Monach, Sonia T Anand, Nathanael R Fillmore, et al.
Health Research Policy and Systems|December 14, 2022
Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigationJennifer La, Nathanael R Fillmore, Nhan V Do, et al.
Cell Reports. Medicine|September 17, 2025
Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication recordsChunlei Zheng, Asif Khan, Daniel Ritter, et al.
Journal of the American Academy of Dermatology|January 10, 2021
Risk factors for thick melanoma among veterans: A cross-sectional studyRebecca I Hartman, Jennifer La, Michael S Chang, et al.
Infection Control and Hospital Epidemiology|November 14, 2023
Longitudinal trends in 30-day mortality attributable to SARS-CoV-2 among vaccinated and unvaccinated US veteran patientsCaitlin A Trottier, Jennifer La, Lucy Li, et al.
Infection Control and Hospital Epidemiology|January 11, 2022
The COVID-19 hospitalization metric in the pre- and postvaccination eras as a measure of pandemic severity: A retrospective, nationwide cohort studyNathanael R Fillmore, Jennifer La, Chunlei Zheng, et al.
International Journal of Clinical Oncology|March 1, 2023
Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patientsApar Kishor Ganti, Nathanael R Fillmore, John Bihn, et al.
Arthritis Care & Research|June 12, 2023
Trends in Fracture Rates Over Two Decades Among Veterans With Ankylosing SpondylitisSali Merjanah, Jean W Liew, John Bihn, et al.
JCO Clinical Cancer Informatics|October 19, 2020
Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs SystemJennifer La, David Cheng, Mary T Brophy, et al.
Ejhaem|November 24, 2025
Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple MyelomaGrace M Ferri, Cenk Yildirim, Nhan V Do, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
MMWR. Morbidity and Mortality Weekly Report|January 25, 2024
Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 - Veterans Health Administration, March-September 2022Paul A Monach, Sonia T Anand, Nathanael R Fillmore, et al.
Health Research Policy and Systems|December 14, 2022
Factors associated with the speed and scope of diffusion of COVID-19 therapeutics in a nationwide healthcare setting: a mixed-methods investigationJennifer La, Nathanael R Fillmore, Nhan V Do, et al.
Cell Reports. Medicine|September 17, 2025
Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication recordsChunlei Zheng, Asif Khan, Daniel Ritter, et al.
Journal of the American Academy of Dermatology|January 10, 2021
Risk factors for thick melanoma among veterans: A cross-sectional studyRebecca I Hartman, Jennifer La, Michael S Chang, et al.
Infection Control and Hospital Epidemiology|November 14, 2023
Longitudinal trends in 30-day mortality attributable to SARS-CoV-2 among vaccinated and unvaccinated US veteran patientsCaitlin A Trottier, Jennifer La, Lucy Li, et al.
Infection Control and Hospital Epidemiology|January 11, 2022
The COVID-19 hospitalization metric in the pre- and postvaccination eras as a measure of pandemic severity: A retrospective, nationwide cohort studyNathanael R Fillmore, Jennifer La, Chunlei Zheng, et al.
International Journal of Clinical Oncology|March 1, 2023
Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patientsApar Kishor Ganti, Nathanael R Fillmore, John Bihn, et al.
Arthritis Care & Research|June 12, 2023
Trends in Fracture Rates Over Two Decades Among Veterans With Ankylosing SpondylitisSali Merjanah, Jean W Liew, John Bihn, et al.
JCO Clinical Cancer Informatics|October 19, 2020
Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs SystemJennifer La, David Cheng, Mary T Brophy, et al.
Ejhaem|November 24, 2025
Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple MyelomaGrace M Ferri, Cenk Yildirim, Nhan V Do, et al.
Pageof 10